Cerebral vasospasm in subarachnoid haemorrhage

被引:2
|
作者
Stura, G [1 ]
Ferrio, MF [1 ]
Bergui, M [1 ]
机构
[1] Univ Turin, Molinette Hosp, Neuroradiol Unit, Dept Neurosci, I-10126 Turin, Italy
来源
RIVISTA DI NEURORADIOLOGIA | 2002年 / 15卷 / 05期
关键词
vasospasm; cerebral aneurysm; subarachnoid haemorrhage; angioplasty; papaverine;
D O I
10.1177/197140090201500519
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In the second and third weeks after a subarachnoid haemorrhage a series of mechanisms causes a decrease of the diameter of the cerebral vessels. These phenomena are globally included in the term "vasospasm". A certain degree of vasospasm is found in the majority of the patients after a subarachnoid bleeding.. This can be detected by instrumental examinations, in particular trans-cranial doppler and angiography. However, only a minor percentage of these patients will suffer clinical consequences. The vasospasm is currently treated by hypertensive-hypervolemic-haemodilution therapy (the so called "HHH" therapy), or may be treated by selective injection of vasoactive substances (Papaverine, nimodipine) or by mechanical dilatation of the involved vessels with balloons, mainly because of an improved medical management and a better monitoring of critical patients the incidence of clinical vasospasm has decreased in the recent years.
引用
收藏
页码:611 / 614
页数:4
相关论文
共 50 条
  • [41] Cerebral vasospasm after subarachnoid haemorrhage of unknown aetiology: A clinical and transcranial Doppler study
    Schaller, C
    Raueiser, B
    Rohde, V
    Hassler, W
    ACTA NEUROCHIRURGICA, 1996, 138 (05) : 560 - 568
  • [42] Reversal of cerebral vasospasm by the nitric oxide donor SNAP in an experimental model of subarachnoid haemorrhage
    Kiris, T
    Karasu, A
    Yavuz, C
    Erdem, T
    Ünal, F
    Hepgül, K
    Baloglu, H
    ACTA NEUROCHIRURGICA, 1999, 141 (12) : 1323 - 1329
  • [43] Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage
    A. Woszczyk
    W. Deinsberger
    D.-K. Böker
    Acta Neurochirurgica, 2003, 145 : 257 - 264
  • [44] The role of intravenous immunoglobulin in the treatment of cerebral vasospasm induced by subarachnoid haemorrhage: An experimental study
    Cengiz, Sahika Liva
    Erdi, Mehmet Fatih
    Avunduk, Mustafa Cihat
    Tosun, Murat
    Ustun, Mehmet Erkan
    Gokce, Recep
    Yosunkaya, Alper
    Baysefer, Alper
    BRAIN INJURY, 2011, 25 (10) : 965 - 971
  • [45] Cerebral vasospasm following aneurysrual subarachnoid haemorrhage: the role of nitric oxide and oxidative stress
    Ramesh, S. Shimoga
    Christopher, R.
    Bhagavatula, I. D.
    Bhat, D. Ishwar
    CEREBROVASCULAR DISEASES, 2016, 41 : 124 - 124
  • [46] Repeat intra-arterial papaverine for recurrent cerebral vasospasm after subarachnoid haemorrhage
    Numaguchi, Y
    Zoarski, GH
    Clouston, JE
    Zagardo, MT
    Simard, JM
    Aldrich, EF
    Sloan, MA
    Maurer, PK
    Okawara, SH
    NEURORADIOLOGY, 1997, 39 (10) : 751 - 759
  • [47] Repeat intra-arterial papaverine for recurrent cerebral vasospasm after subarachnoid haemorrhage
    Y. Numaguchi
    G. H. Zoarski
    J. E. Clouston
    M. T. Zagardo
    J. M. Simard
    E. F. Aldrich
    M. A. Sloan
    P. K. Maurer
    S. H. Okawara
    Neuroradiology, 1997, 39 : 751 - 759
  • [48] Efficacy of intra-arterial nimodipine in the treatment of cerebral vasospasm complicating subarachnoid haemorrhage
    Hui, C
    Lau, KP
    CLINICAL RADIOLOGY, 2005, 60 (09) : 1030 - 1036
  • [49] Leflunomide prevents vasospasm secondary to subarachnoid haemorrhage
    D. Belen
    Ö. Besalti
    K. Yiğitkanlı
    K. Kösemehmetoğlu
    S. Şimşek
    H. Bolay
    Acta Neurochirurgica, 2007, 149 : 1041 - 1048
  • [50] Vasospasm in subarachnoid haemorrhage: Pharmacological treatment.
    Melon, E
    Rimaniol, JM
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 1996, 15 (03): : 366 - 373